NL-OMON35294CompletedNot Applicable
Association of Graves' disease and thymic hyperplasia and the role of TSH receptor antibodies in T cell development - Association of Graves' disease and thymic hyperplasia
Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites30 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Graves' disease
- •radioactive iodine treatment
Exclusion Criteria
- •use of corticosteroids
- •older than 50 years of age
- •psychiatric diseases
Investigators
Similar Trials
Recruiting
Not Applicable
Associatie tussen de ziekte van Graves en thymushyperplasie.ImmunodeficienciesNL-OMON25605Erasmus Medical Center, Rotterdam, The Netherlands30
Completed
Not Applicable
Change of Gut Microbiome in the Treatment of Graves' DiseaseGraves' DiseaseNCT04383795Seoul St. Mary's Hospital29
Completed
Not Applicable
The Role of the Thymus in Myasthenia GravisMyasthenia GravisThymomaNCT01102192Charite University, Berlin, Germany20
Completed
Not Applicable
HIFU vs RAI in the Relapsed Graves' DiseaseGraves DiseaseNCT03013257The University of Hong Kong240
Recruiting
Phase 3
A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' OrbitopathyGraves' OrbitopathyNCT04776993University of Pisa52